WebTellus Therapeutics USA Private Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk demonstrated to induce regeneration of myelin … WebLocation: USA Founded in 2016 Private Company "NEXT-GEN ANTIMICROBIAL THERAPIES FOR LETHAL DRUG-RESISTANT BACTERIAL INFECTIONS. Lysins are enzymes made by bacteriophages. Lysins can break down the bacterial cell wall in a matter of seconds, Due to phage-bacteria coevolution, the chance of developing resistance to …
Shionogi to develop treatment for mycobacterial diseases
WebHsiri Therapeutics, a private biopharmaceutical company, is dedicated to the discovery and development of novel antibiotics to treat multi-drug … Web11 okt. 2024 · 抗酸菌症治療薬に関するHsiri Therapeutic社との新たなライセンス契約の締結について 塩野義製薬 株式会社(本社:大阪市中央区、代表取締役社長:手代木 功、以 … daly city dental clinic
Hsiri Therapeutics, LLC King of Prussia, PA, USA Startup
Web11 okt. 2024 · Hsiri Therapeutics, Inc. is a pre-clinical stage company specializing in novel antimicrobials. Hsiri was founded based on technology and assets licensed from the University of Notre Dame. Hsiri's business model is to acquire discovery phase compounds by license and internal research and to develop them to pharmacologic proof of concept. Web6 jun. 2024 · Hsiri Therapeutics, Inc. is a pre-clinical stage company specializing in novel antimicrobials. Hsiri was founded based on technology and assets licensed from the University of Notre Dame. birdfirst glass